18 annual accounts with figures on one time axis, 40 filings since 1979
peak of €103.2m in 2015
€63.0m▼ 38.9%
peak of €61.8m in 2018
€61.8m▲ 1,205×
peak of €62.3m in 2018
€62.3m▲ 99.3%
€661,292▼ 99.1%
peak of 61 FTE in 2012
18 FTE▼ 11.3%
Board4 names since 2012
-
Owners3 names in the annual accounts
99.99%Name hiddenVisible after signing in and 1 other
Documentsfilings and deeds
30-07-20191 day before the deadline
2018financial year
Result from €51,278 to €61.8mStaff from 20.3 FTE to 18 FTEMerger proposal: to be absorbed by A.M.L.20-11Capital decrease of €26,300,000 to €81,456.6214-11Equity from €31.3m to €62.3mDebts from €71.8m to €661,292
Key points
from the 2018 annual accounts, the last ones filed
Merger: absorbed by A.M.L.
General meeting of 21-12-2018 · Gazette deed
Merger proposal: to be absorbed by A.M.L.
Capital increase of €81,456.62 · Gazette deed
Capital decrease of €26,300,000 to €81,456.62
The capital fell from €26,381,456.62 to €81,456.62 · Gazette deed
Name after signing inVisible after signing in appointed as statutory auditorName hiddenVisible after signing in acts as permanent representative · General meeting of 17-06-2016 · Gazette deed
Absorbed by A.M.L.merger by absorption, January 2019
Activity
“De uitbating van een laboratorium waar,onder de persoonlijke medische aansprakelijkheid van de klinische biologen,vestrekkingen…” (deed in Dutch)From the articlesNo NACE code in the KBO